Clinical Trials Browser

OTHER × Interventional × sagopilone × Clear all

NCT00598507 2013-12-11

Phase II Trial Of ZK-EPO (ZK 219477) (Sagopilone) In Metastatic Melanoma

Phase 2 Completed

35 enrolled 8 charts

Melanoma

NCT00496379 2013-03-14

ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases

Phase 2 Terminated

15 enrolled 10 charts

Brain Neoplasms, Breast Neoplasms, Central Nervous System Diseases